Article
Proteasome inhibitor for treatment of multiple myeloma
lancet oncology
Publication Date
8-1-2005
Document Type
Article
Disciplines
Abstract
Bortezomib is more effective than high-dose dexamethasone for treatment of patients with relapsed multiple myeloma, according to results from the Assessment of Proteasome Inhibition for Extending Remissions
Citation Information
Khabir Ahmed. "Proteasome inhibitor for treatment of multiple myeloma" lancet oncology Vol. 6 Iss. 8 (2005) p. 546 Available at: http://works.bepress.com/khabir_ahmed/71/